These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta. O'Sullivan SE; Kendall DA; Randall MD Eur J Pharmacol; 2005 Jan; 507(1-3):211-21. PubMed ID: 15659311 [TBL] [Abstract][Full Text] [Related]
14. Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed. Pakdeechote P; Dunn WR; Ralevic V Br J Pharmacol; 2007 Nov; 152(5):725-33. PubMed ID: 17641668 [TBL] [Abstract][Full Text] [Related]
15. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture. Kim D; Thayer SA J Neurosci; 2001 May; 21(10):RC146. PubMed ID: 11319244 [TBL] [Abstract][Full Text] [Related]
16. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Ameri A; Wilhelm A; Simmet T Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827 [TBL] [Abstract][Full Text] [Related]
17. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats. Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621 [TBL] [Abstract][Full Text] [Related]